Correlation Between NYSE Composite and Alterity Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Alterity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Alterity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Alterity Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Alterity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Alterity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Alterity Therapeutics.
Diversification Opportunities for NYSE Composite and Alterity Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NYSE and Alterity is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Alterity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alterity Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Alterity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alterity Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Alterity Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Alterity Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 5.32 times less return on investment than Alterity Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 8.62 times less risky than Alterity Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Alterity Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 210.00 in Alterity Therapeutics on October 24, 2024 and sell it today you would earn a total of 118.00 from holding Alterity Therapeutics or generate 56.19% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 99.6% |
Values | Daily Returns |
NYSE Composite vs. Alterity Therapeutics
Performance |
Timeline |
NYSE Composite and Alterity Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Alterity Therapeutics
Pair trading matchups for Alterity Therapeutics
Pair Trading with NYSE Composite and Alterity Therapeutics
The main advantage of trading using opposite NYSE Composite and Alterity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Alterity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alterity Therapeutics will offset losses from the drop in Alterity Therapeutics' long position.NYSE Composite vs. Datadog | NYSE Composite vs. Nasdaq Inc | NYSE Composite vs. Air Lease | NYSE Composite vs. EvoAir Holdings |
Alterity Therapeutics vs. Anebulo Pharmaceuticals | Alterity Therapeutics vs. Pmv Pharmaceuticals | Alterity Therapeutics vs. AN2 Therapeutics | Alterity Therapeutics vs. HCW Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |